MMWR Morb Mortal Wkly Rep. 2013 Feb 1;62(4):66-72.
Vaccinations are recommended throughout life to prevent vaccine-preventable diseases and their sequelae. Adult vaccination coverage, however, remains low for most routinely recommended vaccines and well below Healthy People 2020 targets. In October 2012, the Advisory Committee on Immunization Practices (ACIP) approved the adult immunization schedule for 2013. Apart from influenza vaccination, which is now recommended for all adults, other vaccines recommended for adults target different populations based on age, certain medical conditions, behavioral risk factors (e.g., injection drug use), occupation, travel, and other indications. To assess adult (aged ≥19 years) vaccination coverage for select vaccines, CDC analyzed data from the 2011 National Health Interview Survey (NHIS). This report summarizes the results of that analysis for pneumococcal vaccine, tetanus toxoid-containing vaccines (including tetanus and diphtheria toxoid [Td] with acellular pertussis vaccine [Tdap]), and hepatitis A, hepatitis B, herpes zoster (shingles), and human papillomavirus (HPV) vaccines, by selected characteristics (age, race/ethnicity,† and vaccination target criteria). Influenza vaccination coverage estimates for the 2011-12 influenza season have been published separately. Compared with 2010, the data indicate modest increases in Tdap vaccination among persons aged 19-64 years and HPV vaccination among women, but only little improvement in coverage for the other vaccines among adults in the United States. Coverage for tetanus vaccination (with any tetanus toxoid-containing vaccine) during the past 10 years was unchanged. Substantial increases in vaccination coverage are needed to reduce the occurrence of vaccine-preventable diseases among adults. The Community Preventive Services Task Force and other authorities have recommended that health-care providers incorporate vaccination needs assessment, recommendation, and offer of vaccination into routine clinical practice for adult patients.
疫苗接种建议贯穿一生,以预防疫苗可预防的疾病及其后遗症。然而,大多数常规推荐疫苗的成人接种率仍然很低,远低于“健康人民 2020 年目标”。2012 年 10 月,免疫实践咨询委员会(ACIP)批准了 2013 年成人免疫计划。除流感疫苗外,现在建议所有成年人接种,其他针对成年人的疫苗根据年龄、某些医疗状况、行为危险因素(例如,注射吸毒)、职业、旅行和其他指征,针对不同人群推荐。为评估特定疫苗的成人(年龄≥19 岁)疫苗接种率,CDC 分析了 2011 年全国健康访谈调查(NHIS)的数据。本报告总结了对肺炎球菌疫苗、含破伤风类毒素疫苗(包括破伤风和白喉类毒素[Td]与无细胞百日咳疫苗[Tdap])以及甲型肝炎、乙型肝炎、带状疱疹(带状疱疹)和人乳头瘤病毒(HPV)疫苗的分析结果,根据选定的特征(年龄、种族/族裔,†和疫苗接种目标标准)。2011-12 流感季节的流感疫苗接种覆盖率估计数已单独公布。与 2010 年相比,数据表明 19-64 岁人群 Tdap 疫苗接种率略有增加,女性 HPV 疫苗接种率略有增加,但美国成年人中其他疫苗的覆盖率仅略有改善。过去 10 年,破伤风(任何含破伤风类毒素疫苗)接种率保持不变。需要大幅提高疫苗接种率,以减少成年人中疫苗可预防疾病的发生。社区预防服务工作队和其他权威机构建议医疗保健提供者将疫苗接种需求评估、建议和接种机会纳入成人患者常规临床实践。